Japan-U.S. Research Team IDs Gene Behind Kawasaki Disease (Japan)
This article was originally published in PharmAsia News
Executive Summary
A team of Japanese and U.S. researchers says it has made the first identification of a gene associated with Kawasaki disease that can cause coronary artery aneurysms. The isolated gene is one of several factors believed associated with the disease, which has no cure, and its presence increases by 90 percent the risk of contracting the disease. The protein of the gene is believed to be lacking in people with Kawasaki disease, allowing their immune systems to overreact. (Click here for more
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.